BlinkLab Says European ADHD Study Completes Participant Recruitment, Shares Fall 3%

MT Newswires Live
06/26

BlinkLab (ASX:BB1) said its European attention-deficit/hyperactivity disorder (ADHD) study, being conducted in collaboration with Mental Care Group, completed participant recruitment and the firm's neurometric data collection, enrolling 375 children, according to a Friday Australian bourse filing.

The study is designed to evaluate the firm's objective neurometric measures against comprehensive clinical ADHD diagnoses. The clinical diagnostic reference dataset, completed in the final stage of the study, will be used to evaluate the neurometric measures against diagnostic standards for ADHD.

Its shares fell 3% in recent trading on Friday.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10